Concepedia

Author

Gerald Jäger

University of Graz

Also Known As

G Jager, G Jäger, G. Jäger, Gerald Jäger, Gian-Fadri Jäger

25

Publications

852

Citations

8

H-Index

10

Concepts

All Affiliations

University of GrazUniversity of ViennaKrankenhaus der ElisabethinenKaiser-Franz-Josef-SpitalBarmherzige Schwestern vom heiligen Kreuz
GJ

About

Gerald Jäger is an author at University of Graz specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

106

2

Health Sciences

1

1

24

3

Immunology

1

1

24

4

Pathology

1

1

24

5

Pharmacology

1

1

22

Gerald Jäger

×

7

Publications

793

Citations

7

H-Index

YearCitations

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

Mario Cazzola, Diethelm Messinger, Vittorio Battistel,

Blood

1995

222

Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma

Anders Österborg, MA Boogaerts, R Cimino,

Blood

1996

206

Treatment of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type With Cladribine: A Phase II Study

Gerald Jäger, Peter Neumeister, Ruth I. Brezinschek,

Journal of Clinical Oncology

2002

137

Rituximab for Treatment of Advanced Extranodal Marginal Zone B Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Lymphoma

Markus Raderer, Gerald Jäger, Stefan Brugger,

Oncology

2003

122

First-line treatment of Waldenström's disease with cladribine

Michael Fridrik, Gerald Jäger, C. Baldinger,

Annals of Hematology

1997

60

Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature.

Gerald Jäger, Gerald Höfler, Werner Linkesch,

PubMed

2004

24

Efficacy and toxicity of 2-chlorodeoxyadenosine (cladribine)—2h infusion for 5 days—as first-line treatment for advanced low grade non-Hodgkin’s lymphoma

Michael Fridrik, Gerald Jäger, H. Kienzer,

European Journal of Cancer

1998

22

Page 1